tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Sanofi India Secures Court Approval for Export Rebate Claim

Story Highlights
  • Sanofi India operates in the pharmaceutical industry, offering medicines and vaccines.
  • Gujarat High Court approved Sanofi India’s refund claim, with no material impact on operations.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Sanofi India Secures Court Approval for Export Rebate Claim

Elevate Your Investing Strategy:

Sanofi India Limited ( (IN:SANOFI) ) has provided an update.

Sanofi India Limited announced that the Gujarat High Court has allowed its writ petition for a refund claim of Rs. 83,74,925 for the year 2014. The court directed the company to submit necessary documents to the jurisdictional authority for a rebate claim on export. This decision does not have a material impact on the company’s financial, operational, or other activities.

More about Sanofi India Limited

Sanofi India Limited operates in the pharmaceutical industry, providing a range of healthcare solutions including prescription medicines and vaccines. The company focuses on improving patient health and has a significant presence in the Indian market.

YTD Price Performance: -4.20%

Average Trading Volume: 2,245

Current Market Cap: 131.9B INR

For detailed information about SANOFI stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1